Essex Woodlands Management’s Acura Pharmaceuticals ACUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-1,956,397
| Closed | -$352K | – | 7 |
|
|
2019
Q1 | $352K | Hold |
1,956,397
| – | – | 0.18% | 8 |
|
|
2018
Q4 | $215K | Hold |
1,956,397
| – | – | 0.09% | 8 |
|
|
2018
Q3 | $372K | Hold |
1,956,397
| – | – | 0.08% | 8 |
|
|
2018
Q2 | $704K | Hold |
1,956,397
| – | – | 0.16% | 8 |
|
|
2018
Q1 | $998K | Hold |
1,956,397
| – | – | 0.22% | 9 |
|
|
2017
Q4 | $783K | Hold |
1,956,397
| – | – | 0.14% | 9 |
|
|
2017
Q3 | $880K | Hold |
1,956,397
| – | – | 0.16% | 8 |
|
|
2017
Q2 | $1.1M | Hold |
1,956,397
| – | – | 0.2% | 8 |
|
|
2017
Q1 | $1.18M | Hold |
1,956,397
| – | – | 0.27% | 9 |
|
|
2016
Q4 | $1.51M | Hold |
1,956,397
| – | – | 0.34% | 9 |
|
|
2016
Q3 | $3.13M | Hold |
1,956,397
| – | – | 0.65% | 8 |
|
|
2016
Q2 | $3.62M | Hold |
1,956,397
| – | – | 0.91% | 9 |
|
|
2016
Q1 | $5.54M | Hold |
1,956,397
| – | – | 1.45% | 8 |
|
|
2015
Q4 | $4.89M | Hold |
1,956,397
| – | – | 0.89% | 7 |
|
|
2015
Q3 | $4.6M | Sell |
1,956,397
-18,000
| -0.9% | -$61.2K | 0.84% | 8 |
|
|
2015
Q2 | $9.68M | Sell |
1,974,397
-82,580
| -4% | -$343K | 1.75% | 6 |
|
|
2015
Q1 | $7.73M | Hold |
2,056,977
| – | – | 1.53% | 6 |
|
|
2014
Q4 | $4.4M | Hold |
2,056,977
| – | – | 1.37% | 6 |
|
|
2014
Q3 | $7.63M | Hold |
2,056,977
| – | – | 2.78% | 5 |
|
|
2014
Q2 | $10.7M | Sell |
2,056,977
-2,000
| -0.1% | -$12.1K | 2.22% | 6 |
|
|
2014
Q1 | $14.3M | Hold |
2,058,977
| – | – | 3.64% | 5 |
|
|
2013
Q4 | $16.4M | Hold |
2,058,977
| – | – | 8.24% | 4 |
|
|
2013
Q3 | $18.8M | Hold |
2,058,977
| – | – | 12.44% | 3 |
|
|
2013
Q2 | $18.7M | Buy |
+2,058,977
| New | +$23.3M | 14.34% | 2 |
|
Essex Woodlands Management's ACUR Position: Q2 2019 in Review
Essex Woodlands Management sold out of Acura Pharmaceuticals (ACUR) in Q2 2019, closing a stake of 1,956,397 shares — an estimated $352K sold.
Essex Woodlands Management first reported a position in ACUR in Q2 2013 and held it in 24 quarters. The position peaked at $18.8M in Q3 2013. 1 fund tracked by Wall St. Rank holds ACUR as of Q2 2019.
- Essex Woodlands Management reported no remaining Acura Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
- Essex Woodlands Management sold 1,956,397 Acura Pharmaceuticals shares in Q2 2019, an estimated $352K.
- Essex Woodlands Management first reported a position in Acura Pharmaceuticals in Q2 2013 and held it in 24 quarters.
- Essex Woodlands Management's Acura Pharmaceuticals position peaked at $18.8M in Q3 2013.
- 1 fund tracked by Wall St. Rank held Acura Pharmaceuticals as of Q2 2019.
Based on Essex Woodlands Management's 13F filing for Q2 2019, filed 14 Aug 2019.